These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1565635)

  • 1. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.
    Maki T; Ichikawa T; Blanco R; Porter J
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3434-8. PubMed ID: 1565635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of STZ administration on islet isograft and allograft survival in NOD mice.
    Takayama Y; Ichikawa T; Maki T
    Diabetes; 1993 Feb; 42(2):324-9. PubMed ID: 8425668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
    Arefanian H; Tredget EB; Rajotte RV; Korbutt GS; Gill RG; Rayat GR
    Cell Transplant; 2007; 16(8):787-98. PubMed ID: 18087999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley A; Mandel TE
    Diabetes; 1998 Sep; 47(9):1399-405. PubMed ID: 9726227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4.
    Ogawa N; List JF; Habener JF; Maki T
    Diabetes; 2004 Jul; 53(7):1700-5. PubMed ID: 15220193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone.
    Bradley BJ; Haskins K; La Rosa FG; Lafferty KJ
    Diabetes; 1992 Dec; 41(12):1603-8. PubMed ID: 1446802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive antibody treatment prolongs graft survival in two murine models of segmental pancreas transplantation.
    Purcell LJ; Mottram PL; Mandel TE
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():349-52. PubMed ID: 8225401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
    Chatenoud L; Thervet E; Primo J; Bach JF
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):123-7. PubMed ID: 8278351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
    Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
    J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley AN
    Transpl Immunol; 2002 Jun; 10(1):63-72. PubMed ID: 12182467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
    Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
    Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade.
    Bozulic LD; Huang Y; Xu H; Wen Y; Ildstad ST
    Exp Hematol; 2011 Oct; 39(10):977-85. PubMed ID: 21726515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy.
    Wang T; Singh B; Warnock GL; Rajotte RV
    Diabetes; 1992 Jan; 41(1):114-7. PubMed ID: 1727730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.